Long-term Safety and Tolerability of AFFITOPE AD01

Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001

The purpose of this study is to assess the long-term tolerability and -safety of AFFITOPE AD01 applied during AFFiRiS 001

Inclusion Criteria:

• Written informed consent signed and dated by the patient or the patient's legal representative and the caregiver
• Patients having participated in AFFiRiS 001 and received at least 1 vaccination with AFFITOPE AD01
• Availability of a partner/caregiver knowing the patient and being able to accompany the patient to the visits.

Exclusion Criteria:

• Patients having received no vaccination with AFFITOPE AD01
• Contraindication for MRI imaging
• History of questionable compliance to visit schedule, patients not expected to complete the clinical trial